Vascular Patches Comprehensive Study by Application (Carotid Endarterectomy, Vascular Bypass Surgery, Open Repair of Abdominal Aortic Aneurysms, Others), Material (Biologic Vascular Patches, Synthetic Vascular Patches), End User (Hospitals & Clinics, Ambulatory Surgical Centers) Players and Region - Global Market Outlook to 2030

Vascular Patches Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 7.3%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Vascular Patches Market Scope?
Vascular Patches are produced from polyester-urethane and are characterized by excellent biocompatibility and proven long-term mechanical stability. The elastic material ensures minimum suture hole bleeding and compliance which is unmatched by any other synthetic patch. The microporous structure allows good tissue incorporation. Vascular-Patch is blood tight - no need for pre-clotting or impregnation. The increase in the prevalence of vascular diseases, the rapid rise in the geriatric population, the increase in adoption of biological patches, and the rise in the number of vascular surgeries performed are driving the global vascular patches market.

Influencing Trend:
Increasing Adoption of Biological Patches

Market Growth Drivers:
Rapidly Increasing Geriatric Population and Increase in the Prevalence of Vascular Diseases and Rising Adoption of Biological Patches

Challenges:
Lack of Skilled Professionals

Restraints:
Risk of Immune Response and Serious Complications and Product Failures and Recalls

Opportunities:
Increasing Number of Vascular Surgeries being Performed Worldwide

The Vascular Patches market study is being classified, by Application and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Vascular Patches market throughout the predicted period.

Terumo Corporation (Japan), C. R. Bard, Inc. (United States), B. Braun Melsungen AG (Germany), LeMaitre Vascular, Inc. (United States), Maquet (Germany), W. L. Gore & Associates, Inc. (United States), Admedus (Australia), CryoLife, Inc. (United States), Labcor Laboratórios Ltda (Brazil), Baxter International Inc. (United States) and Edwards Lifesciences Corporation (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Aesculap, Inc. (United States), Braile Biomedica (Brazil), CryoLife, Inc. (United States), W. L. Gore & Associates, Inc (United States), InSitu Technologies (United States), Tissuemed (United Kingdom) and Vascutek (United Kingdom).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Vascular Patches market by Type, Application and Region.

On the basis of geography, the market of Vascular Patches has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Asia Pacific region hold largest market share in the year 2023.

Market Influencers and their Development Strategies
On 13th October 2019, LeMaitre Vascular, Inc. has announced that it has acquired the biologic patch business of Admedus Ltd for USD 15.5 million, of which USD 14.2 million was paid at closing and USD 1.3 million is due in two post-closing installments, as well as potential earnout payments of USD 7.8 million payable based upon the performance of the acquired business as well as other milestones.
In 2022, Labcor Laboratorios' research center is ISO 9001 accredited for technological development in experimental cardiovascular and vascular surgery., In 2021, Anvisa awarded Labcor's new manufacturing unit a Good Manufacturing Practices certificate., In 2021, Axio Biosolutions has announced US Food and Drug Administration (FDA) approval for Axiostat Patch, a product that primarily helps control moderate to severe bleeding in vascular procedures., In 2021, Terumo Corporation announced the launch of a global surgical graft research known as PANTHER. This study is a prospective and retrospective study of a wide range of knitted and woven surgical grafts and cardiovascular patches. and CryoLife, Inc. announced a name change and rebranding to Artivion, Inc. on January 18, 2022. According to the company, the name comes from aorta, innovation and vision.


Key Target Audience
Vascular Patches Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, Hospitals and clinics, Ambulatory surgical centers, End Users and Others

Vascular Patches Market Study: Important Years
AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Historical Period2018-2023
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Vascular Patches Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Vascular Patches industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Application
  • Carotid Endarterectomy
  • Vascular Bypass Surgery
  • Open Repair of Abdominal Aortic Aneurysms
  • Others
By Material
  • Biologic Vascular Patches
  • Synthetic Vascular Patches

By End User
  • Hospitals & Clinics
  • Ambulatory Surgical Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rapidly Increasing Geriatric Population and Increase in the Prevalence of Vascular Diseases
      • 3.2.2. Rising Adoption of Biological Patches
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Increasing Adoption of Biological Patches
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Vascular Patches, by Application, Material, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Vascular Patches (Value)
      • 5.2.1. Global Vascular Patches by: Application (Value)
        • 5.2.1.1. Carotid Endarterectomy
        • 5.2.1.2. Vascular Bypass Surgery
        • 5.2.1.3. Open Repair of Abdominal Aortic Aneurysms
        • 5.2.1.4. Others
      • 5.2.2. Global Vascular Patches by: Material (Value)
        • 5.2.2.1. Biologic Vascular Patches
        • 5.2.2.2. Synthetic Vascular Patches
      • 5.2.3. Global Vascular Patches by: End User (Value)
        • 5.2.3.1. Hospitals & Clinics
        • 5.2.3.2. Ambulatory Surgical Centers
      • 5.2.4. Global Vascular Patches Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Vascular Patches: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Terumo Corporation (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. C. R. Bard, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. B. Braun Melsungen AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. LeMaitre Vascular, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Maquet (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. W. L. Gore & Associates, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Admedus (Australia), CryoLife, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Labcor Laboratórios Ltda (Brazil)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Baxter International Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Edwards Lifesciences Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Vascular Patches Sale, by Application, Material, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Vascular Patches (Value)
      • 7.2.1. Global Vascular Patches by: Application (Value)
        • 7.2.1.1. Carotid Endarterectomy
        • 7.2.1.2. Vascular Bypass Surgery
        • 7.2.1.3. Open Repair of Abdominal Aortic Aneurysms
        • 7.2.1.4. Others
      • 7.2.2. Global Vascular Patches by: Material (Value)
        • 7.2.2.1. Biologic Vascular Patches
        • 7.2.2.2. Synthetic Vascular Patches
      • 7.2.3. Global Vascular Patches by: End User (Value)
        • 7.2.3.1. Hospitals & Clinics
        • 7.2.3.2. Ambulatory Surgical Centers
      • 7.2.4. Global Vascular Patches Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Vascular Patches: by Application(USD Million)
  • Table 2. Vascular Patches Carotid Endarterectomy , by Region USD Million (2018-2023)
  • Table 3. Vascular Patches Vascular Bypass Surgery , by Region USD Million (2018-2023)
  • Table 4. Vascular Patches Open Repair of Abdominal Aortic Aneurysms , by Region USD Million (2018-2023)
  • Table 5. Vascular Patches Others , by Region USD Million (2018-2023)
  • Table 6. Vascular Patches: by Material(USD Million)
  • Table 7. Vascular Patches Biologic Vascular Patches , by Region USD Million (2018-2023)
  • Table 8. Vascular Patches Synthetic Vascular Patches , by Region USD Million (2018-2023)
  • Table 9. Vascular Patches: by End User(USD Million)
  • Table 10. Vascular Patches Hospitals & Clinics , by Region USD Million (2018-2023)
  • Table 11. Vascular Patches Ambulatory Surgical Centers , by Region USD Million (2018-2023)
  • Table 12. South America Vascular Patches, by Country USD Million (2018-2023)
  • Table 13. South America Vascular Patches, by Application USD Million (2018-2023)
  • Table 14. South America Vascular Patches, by Material USD Million (2018-2023)
  • Table 15. South America Vascular Patches, by End User USD Million (2018-2023)
  • Table 16. Brazil Vascular Patches, by Application USD Million (2018-2023)
  • Table 17. Brazil Vascular Patches, by Material USD Million (2018-2023)
  • Table 18. Brazil Vascular Patches, by End User USD Million (2018-2023)
  • Table 19. Argentina Vascular Patches, by Application USD Million (2018-2023)
  • Table 20. Argentina Vascular Patches, by Material USD Million (2018-2023)
  • Table 21. Argentina Vascular Patches, by End User USD Million (2018-2023)
  • Table 22. Rest of South America Vascular Patches, by Application USD Million (2018-2023)
  • Table 23. Rest of South America Vascular Patches, by Material USD Million (2018-2023)
  • Table 24. Rest of South America Vascular Patches, by End User USD Million (2018-2023)
  • Table 25. Asia Pacific Vascular Patches, by Country USD Million (2018-2023)
  • Table 26. Asia Pacific Vascular Patches, by Application USD Million (2018-2023)
  • Table 27. Asia Pacific Vascular Patches, by Material USD Million (2018-2023)
  • Table 28. Asia Pacific Vascular Patches, by End User USD Million (2018-2023)
  • Table 29. China Vascular Patches, by Application USD Million (2018-2023)
  • Table 30. China Vascular Patches, by Material USD Million (2018-2023)
  • Table 31. China Vascular Patches, by End User USD Million (2018-2023)
  • Table 32. Japan Vascular Patches, by Application USD Million (2018-2023)
  • Table 33. Japan Vascular Patches, by Material USD Million (2018-2023)
  • Table 34. Japan Vascular Patches, by End User USD Million (2018-2023)
  • Table 35. India Vascular Patches, by Application USD Million (2018-2023)
  • Table 36. India Vascular Patches, by Material USD Million (2018-2023)
  • Table 37. India Vascular Patches, by End User USD Million (2018-2023)
  • Table 38. South Korea Vascular Patches, by Application USD Million (2018-2023)
  • Table 39. South Korea Vascular Patches, by Material USD Million (2018-2023)
  • Table 40. South Korea Vascular Patches, by End User USD Million (2018-2023)
  • Table 41. Taiwan Vascular Patches, by Application USD Million (2018-2023)
  • Table 42. Taiwan Vascular Patches, by Material USD Million (2018-2023)
  • Table 43. Taiwan Vascular Patches, by End User USD Million (2018-2023)
  • Table 44. Australia Vascular Patches, by Application USD Million (2018-2023)
  • Table 45. Australia Vascular Patches, by Material USD Million (2018-2023)
  • Table 46. Australia Vascular Patches, by End User USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Vascular Patches, by Application USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Vascular Patches, by Material USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Vascular Patches, by End User USD Million (2018-2023)
  • Table 50. Europe Vascular Patches, by Country USD Million (2018-2023)
  • Table 51. Europe Vascular Patches, by Application USD Million (2018-2023)
  • Table 52. Europe Vascular Patches, by Material USD Million (2018-2023)
  • Table 53. Europe Vascular Patches, by End User USD Million (2018-2023)
  • Table 54. Germany Vascular Patches, by Application USD Million (2018-2023)
  • Table 55. Germany Vascular Patches, by Material USD Million (2018-2023)
  • Table 56. Germany Vascular Patches, by End User USD Million (2018-2023)
  • Table 57. France Vascular Patches, by Application USD Million (2018-2023)
  • Table 58. France Vascular Patches, by Material USD Million (2018-2023)
  • Table 59. France Vascular Patches, by End User USD Million (2018-2023)
  • Table 60. Italy Vascular Patches, by Application USD Million (2018-2023)
  • Table 61. Italy Vascular Patches, by Material USD Million (2018-2023)
  • Table 62. Italy Vascular Patches, by End User USD Million (2018-2023)
  • Table 63. United Kingdom Vascular Patches, by Application USD Million (2018-2023)
  • Table 64. United Kingdom Vascular Patches, by Material USD Million (2018-2023)
  • Table 65. United Kingdom Vascular Patches, by End User USD Million (2018-2023)
  • Table 66. Netherlands Vascular Patches, by Application USD Million (2018-2023)
  • Table 67. Netherlands Vascular Patches, by Material USD Million (2018-2023)
  • Table 68. Netherlands Vascular Patches, by End User USD Million (2018-2023)
  • Table 69. Rest of Europe Vascular Patches, by Application USD Million (2018-2023)
  • Table 70. Rest of Europe Vascular Patches, by Material USD Million (2018-2023)
  • Table 71. Rest of Europe Vascular Patches, by End User USD Million (2018-2023)
  • Table 72. MEA Vascular Patches, by Country USD Million (2018-2023)
  • Table 73. MEA Vascular Patches, by Application USD Million (2018-2023)
  • Table 74. MEA Vascular Patches, by Material USD Million (2018-2023)
  • Table 75. MEA Vascular Patches, by End User USD Million (2018-2023)
  • Table 76. Middle East Vascular Patches, by Application USD Million (2018-2023)
  • Table 77. Middle East Vascular Patches, by Material USD Million (2018-2023)
  • Table 78. Middle East Vascular Patches, by End User USD Million (2018-2023)
  • Table 79. Africa Vascular Patches, by Application USD Million (2018-2023)
  • Table 80. Africa Vascular Patches, by Material USD Million (2018-2023)
  • Table 81. Africa Vascular Patches, by End User USD Million (2018-2023)
  • Table 82. North America Vascular Patches, by Country USD Million (2018-2023)
  • Table 83. North America Vascular Patches, by Application USD Million (2018-2023)
  • Table 84. North America Vascular Patches, by Material USD Million (2018-2023)
  • Table 85. North America Vascular Patches, by End User USD Million (2018-2023)
  • Table 86. United States Vascular Patches, by Application USD Million (2018-2023)
  • Table 87. United States Vascular Patches, by Material USD Million (2018-2023)
  • Table 88. United States Vascular Patches, by End User USD Million (2018-2023)
  • Table 89. Canada Vascular Patches, by Application USD Million (2018-2023)
  • Table 90. Canada Vascular Patches, by Material USD Million (2018-2023)
  • Table 91. Canada Vascular Patches, by End User USD Million (2018-2023)
  • Table 92. Mexico Vascular Patches, by Application USD Million (2018-2023)
  • Table 93. Mexico Vascular Patches, by Material USD Million (2018-2023)
  • Table 94. Mexico Vascular Patches, by End User USD Million (2018-2023)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Vascular Patches: by Application(USD Million)
  • Table 106. Vascular Patches Carotid Endarterectomy , by Region USD Million (2025-2030)
  • Table 107. Vascular Patches Vascular Bypass Surgery , by Region USD Million (2025-2030)
  • Table 108. Vascular Patches Open Repair of Abdominal Aortic Aneurysms , by Region USD Million (2025-2030)
  • Table 109. Vascular Patches Others , by Region USD Million (2025-2030)
  • Table 110. Vascular Patches: by Material(USD Million)
  • Table 111. Vascular Patches Biologic Vascular Patches , by Region USD Million (2025-2030)
  • Table 112. Vascular Patches Synthetic Vascular Patches , by Region USD Million (2025-2030)
  • Table 113. Vascular Patches: by End User(USD Million)
  • Table 114. Vascular Patches Hospitals & Clinics , by Region USD Million (2025-2030)
  • Table 115. Vascular Patches Ambulatory Surgical Centers , by Region USD Million (2025-2030)
  • Table 116. South America Vascular Patches, by Country USD Million (2025-2030)
  • Table 117. South America Vascular Patches, by Application USD Million (2025-2030)
  • Table 118. South America Vascular Patches, by Material USD Million (2025-2030)
  • Table 119. South America Vascular Patches, by End User USD Million (2025-2030)
  • Table 120. Brazil Vascular Patches, by Application USD Million (2025-2030)
  • Table 121. Brazil Vascular Patches, by Material USD Million (2025-2030)
  • Table 122. Brazil Vascular Patches, by End User USD Million (2025-2030)
  • Table 123. Argentina Vascular Patches, by Application USD Million (2025-2030)
  • Table 124. Argentina Vascular Patches, by Material USD Million (2025-2030)
  • Table 125. Argentina Vascular Patches, by End User USD Million (2025-2030)
  • Table 126. Rest of South America Vascular Patches, by Application USD Million (2025-2030)
  • Table 127. Rest of South America Vascular Patches, by Material USD Million (2025-2030)
  • Table 128. Rest of South America Vascular Patches, by End User USD Million (2025-2030)
  • Table 129. Asia Pacific Vascular Patches, by Country USD Million (2025-2030)
  • Table 130. Asia Pacific Vascular Patches, by Application USD Million (2025-2030)
  • Table 131. Asia Pacific Vascular Patches, by Material USD Million (2025-2030)
  • Table 132. Asia Pacific Vascular Patches, by End User USD Million (2025-2030)
  • Table 133. China Vascular Patches, by Application USD Million (2025-2030)
  • Table 134. China Vascular Patches, by Material USD Million (2025-2030)
  • Table 135. China Vascular Patches, by End User USD Million (2025-2030)
  • Table 136. Japan Vascular Patches, by Application USD Million (2025-2030)
  • Table 137. Japan Vascular Patches, by Material USD Million (2025-2030)
  • Table 138. Japan Vascular Patches, by End User USD Million (2025-2030)
  • Table 139. India Vascular Patches, by Application USD Million (2025-2030)
  • Table 140. India Vascular Patches, by Material USD Million (2025-2030)
  • Table 141. India Vascular Patches, by End User USD Million (2025-2030)
  • Table 142. South Korea Vascular Patches, by Application USD Million (2025-2030)
  • Table 143. South Korea Vascular Patches, by Material USD Million (2025-2030)
  • Table 144. South Korea Vascular Patches, by End User USD Million (2025-2030)
  • Table 145. Taiwan Vascular Patches, by Application USD Million (2025-2030)
  • Table 146. Taiwan Vascular Patches, by Material USD Million (2025-2030)
  • Table 147. Taiwan Vascular Patches, by End User USD Million (2025-2030)
  • Table 148. Australia Vascular Patches, by Application USD Million (2025-2030)
  • Table 149. Australia Vascular Patches, by Material USD Million (2025-2030)
  • Table 150. Australia Vascular Patches, by End User USD Million (2025-2030)
  • Table 151. Rest of Asia-Pacific Vascular Patches, by Application USD Million (2025-2030)
  • Table 152. Rest of Asia-Pacific Vascular Patches, by Material USD Million (2025-2030)
  • Table 153. Rest of Asia-Pacific Vascular Patches, by End User USD Million (2025-2030)
  • Table 154. Europe Vascular Patches, by Country USD Million (2025-2030)
  • Table 155. Europe Vascular Patches, by Application USD Million (2025-2030)
  • Table 156. Europe Vascular Patches, by Material USD Million (2025-2030)
  • Table 157. Europe Vascular Patches, by End User USD Million (2025-2030)
  • Table 158. Germany Vascular Patches, by Application USD Million (2025-2030)
  • Table 159. Germany Vascular Patches, by Material USD Million (2025-2030)
  • Table 160. Germany Vascular Patches, by End User USD Million (2025-2030)
  • Table 161. France Vascular Patches, by Application USD Million (2025-2030)
  • Table 162. France Vascular Patches, by Material USD Million (2025-2030)
  • Table 163. France Vascular Patches, by End User USD Million (2025-2030)
  • Table 164. Italy Vascular Patches, by Application USD Million (2025-2030)
  • Table 165. Italy Vascular Patches, by Material USD Million (2025-2030)
  • Table 166. Italy Vascular Patches, by End User USD Million (2025-2030)
  • Table 167. United Kingdom Vascular Patches, by Application USD Million (2025-2030)
  • Table 168. United Kingdom Vascular Patches, by Material USD Million (2025-2030)
  • Table 169. United Kingdom Vascular Patches, by End User USD Million (2025-2030)
  • Table 170. Netherlands Vascular Patches, by Application USD Million (2025-2030)
  • Table 171. Netherlands Vascular Patches, by Material USD Million (2025-2030)
  • Table 172. Netherlands Vascular Patches, by End User USD Million (2025-2030)
  • Table 173. Rest of Europe Vascular Patches, by Application USD Million (2025-2030)
  • Table 174. Rest of Europe Vascular Patches, by Material USD Million (2025-2030)
  • Table 175. Rest of Europe Vascular Patches, by End User USD Million (2025-2030)
  • Table 176. MEA Vascular Patches, by Country USD Million (2025-2030)
  • Table 177. MEA Vascular Patches, by Application USD Million (2025-2030)
  • Table 178. MEA Vascular Patches, by Material USD Million (2025-2030)
  • Table 179. MEA Vascular Patches, by End User USD Million (2025-2030)
  • Table 180. Middle East Vascular Patches, by Application USD Million (2025-2030)
  • Table 181. Middle East Vascular Patches, by Material USD Million (2025-2030)
  • Table 182. Middle East Vascular Patches, by End User USD Million (2025-2030)
  • Table 183. Africa Vascular Patches, by Application USD Million (2025-2030)
  • Table 184. Africa Vascular Patches, by Material USD Million (2025-2030)
  • Table 185. Africa Vascular Patches, by End User USD Million (2025-2030)
  • Table 186. North America Vascular Patches, by Country USD Million (2025-2030)
  • Table 187. North America Vascular Patches, by Application USD Million (2025-2030)
  • Table 188. North America Vascular Patches, by Material USD Million (2025-2030)
  • Table 189. North America Vascular Patches, by End User USD Million (2025-2030)
  • Table 190. United States Vascular Patches, by Application USD Million (2025-2030)
  • Table 191. United States Vascular Patches, by Material USD Million (2025-2030)
  • Table 192. United States Vascular Patches, by End User USD Million (2025-2030)
  • Table 193. Canada Vascular Patches, by Application USD Million (2025-2030)
  • Table 194. Canada Vascular Patches, by Material USD Million (2025-2030)
  • Table 195. Canada Vascular Patches, by End User USD Million (2025-2030)
  • Table 196. Mexico Vascular Patches, by Application USD Million (2025-2030)
  • Table 197. Mexico Vascular Patches, by Material USD Million (2025-2030)
  • Table 198. Mexico Vascular Patches, by End User USD Million (2025-2030)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Vascular Patches: by Application USD Million (2018-2023)
  • Figure 5. Global Vascular Patches: by Material USD Million (2018-2023)
  • Figure 6. Global Vascular Patches: by End User USD Million (2018-2023)
  • Figure 7. South America Vascular Patches Share (%), by Country
  • Figure 8. Asia Pacific Vascular Patches Share (%), by Country
  • Figure 9. Europe Vascular Patches Share (%), by Country
  • Figure 10. MEA Vascular Patches Share (%), by Country
  • Figure 11. North America Vascular Patches Share (%), by Country
  • Figure 12. Global Vascular Patches share by Players 2023 (%)
  • Figure 13. Global Vascular Patches share by Players (Top 3) 2023(%)
  • Figure 14. Global Vascular Patches share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 17. Terumo Corporation (Japan) Revenue: by Geography 2023
  • Figure 18. C. R. Bard, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. C. R. Bard, Inc. (United States) Revenue: by Geography 2023
  • Figure 20. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 21. B. Braun Melsungen AG (Germany) Revenue: by Geography 2023
  • Figure 22. LeMaitre Vascular, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. LeMaitre Vascular, Inc. (United States) Revenue: by Geography 2023
  • Figure 24. Maquet (Germany) Revenue, Net Income and Gross profit
  • Figure 25. Maquet (Germany) Revenue: by Geography 2023
  • Figure 26. W. L. Gore & Associates, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. W. L. Gore & Associates, Inc. (United States) Revenue: by Geography 2023
  • Figure 28. Admedus (Australia), CryoLife, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Admedus (Australia), CryoLife, Inc. (United States) Revenue: by Geography 2023
  • Figure 30. Labcor Laboratórios Ltda (Brazil) Revenue, Net Income and Gross profit
  • Figure 31. Labcor Laboratórios Ltda (Brazil) Revenue: by Geography 2023
  • Figure 32. Baxter International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Baxter International Inc. (United States) Revenue: by Geography 2023
  • Figure 34. Edwards Lifesciences Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. Edwards Lifesciences Corporation (United States) Revenue: by Geography 2023
  • Figure 36. Global Vascular Patches: by Application USD Million (2025-2030)
  • Figure 37. Global Vascular Patches: by Material USD Million (2025-2030)
  • Figure 38. Global Vascular Patches: by End User USD Million (2025-2030)
  • Figure 39. South America Vascular Patches Share (%), by Country
  • Figure 40. Asia Pacific Vascular Patches Share (%), by Country
  • Figure 41. Europe Vascular Patches Share (%), by Country
  • Figure 42. MEA Vascular Patches Share (%), by Country
  • Figure 43. North America Vascular Patches Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Terumo Corporation (Japan)
  • C. R. Bard, Inc. (United States)
  • B. Braun Melsungen AG (Germany)
  • LeMaitre Vascular, Inc. (United States)
  • Maquet (Germany)
  • W. L. Gore & Associates, Inc. (United States)
  • Admedus (Australia), CryoLife, Inc. (United States)
  • Labcor Laboratórios Ltda (Brazil)
  • Baxter International Inc. (United States)
  • Edwards Lifesciences Corporation (United States)
Additional players considered in the study are as follows:
Aesculap, Inc. (United States) , Braile Biomedica (Brazil) , CryoLife, Inc. (United States) , W. L. Gore & Associates, Inc (United States) , InSitu Technologies (United States) , Tissuemed (United Kingdom) , Vascutek (United Kingdom)
Select User Access Type

Key Highlights of Report


Apr 2024 162 Pages 56 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Vascular Patches market are Terumo Corporation (Japan), C. R. Bard, Inc. (United States), B. Braun Melsungen AG (Germany), LeMaitre Vascular, Inc. (United States), Maquet (Germany), W. L. Gore & Associates, Inc. (United States), Admedus (Australia), CryoLife, Inc. (United States), Labcor Laboratórios Ltda (Brazil), Baxter International Inc. (United States) and Edwards Lifesciences Corporation (United States).
In this highly competitive & fast evolving Vascular Patches industry, the top strategic priorities would remain consistent like innovation, R&D, and M&A.
Carotid Endarterectomy, Vascular Bypass Surgery, Open Repair of Abdominal Aortic Aneurysms and Others are the potential customers of Vascular Patches industry.
The Global Vascular Patches market is expected to see a growth of 7.3% during projected year 2023 to 2030.

Know More About Global Vascular Patches Report?